Literature DB >> 22273361

Explorative evaluation of the impact of premenstrual disorder on daily functioning and quality of life.

Lothar A J Heinemann1, Thai Do Minh, Anna Filonenko, Kerstin Uhl-Hochgräber.   

Abstract

OBJECTIVES: : To assess the effects of premenstrual disorders on health-related quality of life (HR-QOL), hobbies and social activities, and relationships with others in the multinational IMPACT study.
METHODS: : Women aged 15-45 years were screened for suspected premenstrual dysphoric disorder (PMDD) and premenstrual syndrome (PMS) and invited to participate in this web-based study. Based on the Daily Record of Severity of Problems (DRSP), prospectively assessed over two observational cycles, participants were grouped into two categories: no perceived symptoms/mild PMS or moderate-to-severe PMS/PMDD. HR-QOL was assessed retrospectively at baseline using the SF-12.
RESULTS: : Overall, 1477 women started the study. Of these, 822 (56%) completed the DRSP and SF-12 questionnaires as planned. Moderate-to-severe PMS/PMDD was associated with a reduction in HR-QOL compared with no perceived symptoms/mild PMS for both mental component scores (34.5 ± 8.7 vs 39.0 ± 9.5) and physical component scores (48.9 ± 7.9 vs 51.1 ± 7.2). Women with moderate-to-severe PMS/PMDD experienced a significantly greater mean number of days with at least moderate interference with hobbies or social activities (5.6 vs 1.1 day; p < 0.05, t-test), and relationships with others (5.4 vs 1.1 day) than those with no perceived symptoms/mild PMS.
CONCLUSIONS: : Moderate-to-severe PMS/PMDD has a negative impact on HR-QOL, hobbies and social activities, and relationships with others. Studies with a confirmatory design are needed to confirm these results.

Entities:  

Year:  2010        PMID: 22273361     DOI: 10.2165/11533750-000000000-00000

Source DB:  PubMed          Journal:  Patient        ISSN: 1178-1653            Impact factor:   3.883


  14 in total

1.  Daily Record of Severity of Problems (DRSP): reliability and validity.

Authors:  J Endicott; J Nee; W Harrison
Journal:  Arch Womens Ment Health       Date:  2005-09-20       Impact factor: 3.633

2.  Evaluating the criteria used for identification of PMS.

Authors:  Bonnie B Dean; Jeff E Borenstein; Kevin Knight; Kimberly Yonkers
Journal:  J Womens Health (Larchmt)       Date:  2006-06       Impact factor: 2.681

3.  Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation.

Authors:  Teri B Pearlstein; Gloria A Bachmann; Howard A Zacur; Kimberly A Yonkers
Journal:  Contraception       Date:  2005-11-02       Impact factor: 3.375

4.  Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.

Authors:  K A Yonkers; U Halbreich; E Freeman; C Brown; J Endicott; E Frank; B Parry; T Pearlstein; S Severino; A Stout; A Stone; W Harrison
Journal:  JAMA       Date:  1997-09-24       Impact factor: 56.272

5.  Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.

Authors:  Kimberly A Yonkers; Candace Brown; Teri B Pearlstein; Marie Foegh; Carole Sampson-Landers; Andrea Rapkin
Journal:  Obstet Gynecol       Date:  2005-09       Impact factor: 7.661

6.  The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France.

Authors:  T R Hylan; K Sundell; R Judge
Journal:  J Womens Health Gend Based Med       Date:  1999-10

7.  Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism and productivity.

Authors:  Lothar A J Heinemann; Thai Do Minh; Anna Filonenko; Kerstin Uhl-Hochgräber
Journal:  Womens Health Issues       Date:  2010 Jan-Feb

8.  Health status among women with menstrual symptoms.

Authors:  Karen Barnard; Susan M Frayne; Katherine M Skinner; Lisa M Sullivan
Journal:  J Womens Health (Larchmt)       Date:  2003-11       Impact factor: 2.681

9.  Perception of family and work environments in women with premenstrual syndrome.

Authors:  A R Kuczmierczyk; A H Labrum; C C Johnson
Journal:  J Psychosom Res       Date:  1992-12       Impact factor: 3.006

10.  Differences in symptom scores and health outcomes in premenstrual syndrome.

Authors:  Jeff E Borenstein; Bonnie B Dean; Eckhard Leifke; Paul Korner; Kimberly A Yonkers
Journal:  J Womens Health (Larchmt)       Date:  2007-10       Impact factor: 2.681

View more
  7 in total

1.  Personal history of major depression may put women at risk for premenstrual dysphoric symptomatology.

Authors:  Eynav E Accortt; Anya V Kogan; John J B Allen
Journal:  J Affect Disord       Date:  2013-06-22       Impact factor: 4.839

2.  Health related quality of life among adolescents with premenstrual disorders: a cross sectional study.

Authors:  Mahin Delara; Fazlollah Ghofranipour; Parviz Azadfallah; Sedigheh Sadat Tavafian; Anoushirvan Kazemnejad; Ali Montazeri
Journal:  Health Qual Life Outcomes       Date:  2012-01-01       Impact factor: 3.186

3.  Licit Substance Use and Premenstrual Syndrome Symptom Severity in Female College Students.

Authors:  Kathryn Polak; Pamela Nora; Bridget Perry; Caitlin Martin; Pam Dillon; Leroy Thacker; Sarah Nance; Susan Kornstein; Dace Svikis
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-05-02

4.  Lowered Plasma Steady-State Levels of Progesterone Combined With Declining Progesterone Levels During the Luteal Phase Predict Peri-Menstrual Syndrome and Its Major Subdomains.

Authors:  Chutima Roomruangwong; André F Carvalho; Frank Comhaire; Michael Maes
Journal:  Front Psychol       Date:  2019-10-30

5.  Influence of Childhood Maltreatment, Adulthood Stressful Life Events, and Affective Temperaments on Premenstrual Mental Symptoms of Nonclinical Adult Volunteers.

Authors:  Yumi Wakatsuki; Takeshi Inoue; Naoki Hashimoto; Yota Fujimura; Jiro Masuya; Masahiko Ichiki; Hajime Tanabe; Ichiro Kusumi
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-06       Impact factor: 2.570

6.  Roles of childhood maltreatment, personality traits, and life stress in the prediction of severe premenstrual symptoms.

Authors:  Chihiro Morishita; Takeshi Inoue; Mina Honyashiki; Miki Ono; Yoshio Iwata; Hajime Tanabe; Ichiro Kusumi; Jiro Masuya
Journal:  Biopsychosoc Med       Date:  2022-04-28

7.  Social stimulation and corticolimbic reactivity in premenstrual dysphoric disorder: a preliminary study.

Authors:  Inger Sundström-Poromaa; Mats Fredrikson; Malin Gingnell; Victoria Ahlstedt; Elin Bannbers; Johan Wikström
Journal:  Biol Mood Anxiety Disord       Date:  2014-02-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.